Certified by Founder Lodge
Triumvira Immunologics, Inc.
United States - Austin, Texas
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Triumvira Immunologics, Inc., our team is dedicated to a vision of finding a cure and providing new hope for patients with life-threatening disease.
Co-founded in 2015 by licensing tech
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 17 ,2022 | Series A | $100,000,000 |
B Capital
Northpond Ventures
ATEM Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
